pelvic floor exercise therapy for urinary incontinence after prostate surgery
is not effective as previously thought to be. Urinary incontinence is a common
complication of prostate surgery. In spite of inconclusive evidences men are
often advised to do pelvic floor exercises. The recent study tried to find out
if formal one-to-one pelvic floor muscle training reduces incontinence.
aim at toning the pelvic floor muscles. Pelvic-floor muscle training
mostly advised for women following delivery. Its effectiveness in women is well
established. But there is lack of conclusive evidence for its use in men
Surgical management of
diseases of the prostate often results in urinary incontinence in men, i.e.
lose of voluntary control over urination. Both the well-known operations called
and transurethral resection of the prostate
are associated with this risk, despite
improvements in surgical technology and techniques.
in the recent trials (two trials were performed) were the ones with urinary
incontinence six weeks after surgery for radical prostatectomy (trial one) or
transurethral resection of the prostate (trial two). They were randomly
apportioned to receive four sessions with a therapist over three months, or
standard care and lifestyle advice.
12 months revealed no significant difference in the rate of urinary
incontinence in the intervention or control groups in either of the trials. No
adverse effects were noticed. This meant one-to-one conservative physical
therapy would not be a cost effective or efficient strategy. Standard care and
lifestyle advice would be more viable.
nations cannot afford such high mean costs per patient. Thus the hunt for the best management for men with persistent incontinence after prostate
surgery may continue. Muscle training is not the only clinical tool available
for the purpose. The efficacy of alternatives like biofeedback training and supportive devices needs to be
incontinence in men after formal one-to-one pelvic-floor muscle training
following radical prostatectomy or transurethral resection of the prostate
(MAPS): two parallel randomised controlled trials; Cathryn Glazener et al; The